Medical genetics and genomic medicine in Turkey: a bright future at a new era in life sciences.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Egypt Genome: Towards an African new genomic era.Journal of advanced research · 2025
   Review
2. Rare disease emerging as a global public health priority.Frontiers in public health · 2022
   Review
3. The genetic structure of the Turkish population reveals high levels of variation and admixture.Proceedings of the National Academy of Sciences of the United States of America · 2021
   Article
4. Looking back and looking forward.Molecular genetics & genomic medicine · 2018
   Article
5. Medical genetics and genomic medicine in Turkey: a bright future at a new era in life sciences.Molecular genetics & genomic medicine · 2017
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract